Search results
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 6 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 3 days agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 4 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 6 hours agoPfizer and Moderna are also planning to prepare JN.1-focused boosters. Novavax stock has been on a...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 4 days agoOn Monday, RBC (TSX:RY) Capital Markets adjusted its outlook on Moderna (NASDAQ:MRNA) shares,...
FDA Green-Lights Moderna Vaccine for Older Adults | Newswise
Newswise· 21 hours agoThe US Food and Drug Administration has approved Moderna’s mRNA vaccine for older adults to protect against respiratory syncytial virus (RSV). According to a company press ...
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 6 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via AOL· 4 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 1 day agoThe Food and Drug Administration (FDA) has approved mRESVIA, a new vaccine made by Moderna, to help...
Moderna wins second product approval with RSV vaccine
Market Watch· 6 days agoModerna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory...